[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100534852":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":39,"centralContacts":43,"locations":49,"responsibleParty":67,"collaborators":30,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":30,"eligibilityCriteria":74,"healthyVolunteers":71,"sex":75,"minAge":76,"maxAge":30,"enrollmentInfo":77,"targetDuration":30,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":51,"whyStopped":30,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":99},{"fullName":5,"class":6},"Wake Forest University Health Sciences","OTHER",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Demonstration","ACTIVE_COMPARATOR","Observe a live demonstration instructing how to dispense 1 fingertip unit (FTU) of medication (triamcinolone cream) per 1% body surface area",[13],"Other: Demonstration of applying triamcinolone cream",{"label":15,"type":16,"description":17,"interventionNames":18},"Mobile Application","EXPERIMENTAL","Additional mobile application that provides instructions to apply the medication (triamcinolone cream)",[19],"Behavioral: Mobile App Use",{"label":21,"type":6,"description":22,"interventionNames":23},"Written\u002Fverbal instructions only","Standard of care written\u002Fverbal instructions only",[24],"Other: Standard of Care",[26,31,36],{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"Demonstration of applying triamcinolone cream","Live demonstration of applying 1 fingertip unit of triamcinolone cream",[9],null,{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":30},"BEHAVIORAL","Mobile App Use","Additional mobile application that provides amount dispensed and adherence data.",[15],{"type":6,"name":37,"description":21,"armGroupLabels":38,"otherNames":30},"Standard of Care",[21],[40],{"name":41,"affiliation":5,"role":42},"Steven R Feldman, MD, PhD","PRINCIPAL_INVESTIGATOR",[44],{"name":45,"role":46,"phone":47,"phoneExt":30,"email":48},"Irma Richardson, MHA","CONTACT","336.716.2903","irichard@wakehealth.edu",[50],{"facility":5,"status":51,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"RECRUITING","Winston-Salem","North Carolina","27157","United States","US",{"type":58,"coordinates":59},"Point",[60,61],-80.24422,36.09986,{"lat":61,"lon":60},[64,66],{"name":45,"role":46,"phone":65,"phoneExt":30,"email":48},"336-716-2903",{"name":41,"role":42,"phone":30,"phoneExt":30,"email":30},{"type":68,"investigatorFullName":30,"investigatorTitle":30,"investigatorAffiliation":30,"oldNameTitle":30,"oldOrganization":30},"SPONSOR","100534852","topical-treatment-for-atopic-dermatitis-100534852",false,"NCT06244212","Topical Treatment for Atopic Dermatitis","Inclusion Criteria:\n\n* Diagnosis of skin dermatitis\n* Age \\> 9\n* Ability to return for a one-week clinical studies follow-up\n* Patients who are candidates for treatment with 0.1% triamcinolone ointment (even if they weren't in the study)\n* Adult or pediatric patients with active dermatitis who receive dermatologic care at Atrium Health Wake Forest Baptist, Department of Dermatology.\n\nExclusion Criteria:\n\n* Patients without the diagnosis of skin dermatitis\n* Inability to return for a one week follow up appointment\n* Body Surface Area (BSA) affected \\\u003C2%","ALL","9 Years",{"count":78,"type":79},30,"ESTIMATED","INTERVENTIONAL",[82],"NA","Medication adherence is a poorly studied phenomenon that challenges both patients and physicians. 50% of individuals with chronic disease are not adherent to their medication regimen. Within the United States, non-adherence to medical treatment leads to approximately $100 billion in hospital admission costs. While the issue of adherence is not limited to any particular field of medicine, non-adherence occurs in approximately one-third to one-half of dermatological patients. Non-adherence is of importance as it is a significant cause of treatment failure, resulting in worse quality of life, worse health outcomes, and increased insurance costs.",[85],"Atopic Dermatitis",[87,88,89],"Medication adherence","topical medications","Triamcinolone","2026-08-03",{"date":92,"type":93},"2026-08-04","ACTUAL",{"date":95,"type":93},"2024-09-19",{"date":97,"type":79},"2027-11",{"name":5,"class":6},1]